Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

2016204 citationsReviewgold Open Access

Authors

Gemma Currie · British Heart Foundation

Alison Taylor · British Heart Foundation

Toshiro Fujita · The University of Tokyo

Hiroshi Ohtsu · National Center for Global Health and Medicine

Morten Lindhardt · Steno Diabetes Center

Peter Rossing · Aarhus University

Lene Boesby ·

Abstract

Mineralocorticoid receptor antagonism reduces blood pressure and urinary protein/albumin excretion with a quantifiable risk of hyperkalaemia above predefined study upper limit.

Topics & Keywords

Hormonal Regulation and Hypertension Blood Pressure and Hypertension Studies Birth, Development, and Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMC Nephrology

Volume 17, Issue 1, pp. 127-127

DOI: 10.1186/s12882-016-0337-0

Field-Weighted Citation Impact: 10.15